Financhill
Sell
31

HR Quote, Financials, Valuation and Earnings

Last price:
$17.41
Seasonality move :
0.83%
Day range:
$17.00 - $17.43
52-week range:
$14.09 - $18.97
Dividend yield:
5.92%
P/E ratio:
--
P/S ratio:
5.16x
P/B ratio:
1.31x
Volume:
2.3M
Avg. volume:
2.7M
1-year change:
3.26%
Market cap:
$6.1B
Revenue:
$1.2B
EPS (TTM):
-$0.71

Analysts' Opinion

  • Consensus Rating
    Healthcare Realty Trust, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $19.40, Healthcare Realty Trust, Inc. has an estimated upside of 11.49% from its current price of $17.40.
  • Price Target Downside
    According to analysts, the lowest downside price target is $18.00 representing -- downside risk from its current price of $17.40.

Fair Value

  • According to the consensus of 10 analysts, Healthcare Realty Trust, Inc. has 11.49% upside to fair value with a price target of $19.40 per share.

HR vs. S&P 500

  • Over the past 5 trading days, Healthcare Realty Trust, Inc. has underperformed the S&P 500 by -3.25% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Healthcare Realty Trust, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Healthcare Realty Trust, Inc. revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Healthcare Realty Trust, Inc. reported revenues of $286.3M.

Earnings Growth

  • Healthcare Realty Trust, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Healthcare Realty Trust, Inc. reported earnings per share of $0.04.
Enterprise value:
10.4B
EV / Invested capital:
--
Price / LTM sales:
5.16x
EV / EBIT:
109.70x
EV / Revenue:
8.82x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
82.04x
Price / Operating cash flow:
47.95x
Enterprise value / EBITDA:
15.81x
Gross Profit (TTM):
$167.5M
Return On Assets:
-2.5%
Net Income Margin (TTM):
-21.34%
Return On Equity:
-5.09%
Return On Invested Capital:
-2.57%
Operating Margin:
12.01%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $1.3B $1.3B $1.2B $309.8M $286.3M
Gross Profit $112.6M $119.7M $167.5M $35M $48.2M
Operating Income $49.8M $36.4M $94.9M $813K $34.4M
EBITDA $780.5M $711.6M $658.9M $161.1M $161.8M
Diluted EPS -$0.74 -$1.78 -$0.71 -$0.31 $0.04
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $98.1M $315.9M $388.2M $370.9M $426.9M
Total Assets $4.3B $13.8B $12.6B $10.7B $9.2B
Current Liabilities $86.4M $246.6M $214.5M $225.9M $348.3M
Total Liabilities $2.1B $6.2B $5.7B $5.3B $4.5B
Total Equity $2.2B $7.7B $6.9B $5.3B $4.7B
Total Debt $1.9B $5.8B $5.3B $5.2B $4.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations $499.8M $501.6M $457.1M $138M $132.3M
Cash From Investing $349.1M $900.2M $710M $418.7M $526.3M
Cash From Financing -$884.2M -$1.4B -$1.2B -$513.9M -$676M
Free Cash Flow $268.8M $252.6M $126.9M $75.8M $45.8M
HR
Sector
Market Cap
$6.1B
$894.5M
Price % of 52-Week High
--
84.55%
Dividend Yield
5.92%
3.65%
Shareholder Yield
9.74%
3.56%
1-Year Price Total Return
3.26%
--
Beta (5-Year)
0.843
0.596
Dividend yield:
5.92%
Annualized payout:
$1.10
Payout ratio:
603.02%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $17.13
200-day SMA
Buy
Level $17.32
Bollinger Bands (100)
Sell
Level 16.92 - 18.16
Chaikin Money Flow
Buy
Level 285.1M
20-day SMA
Sell
Level $17.68
Relative Strength Index (RSI14)
Sell
Level 46.08
ADX Line
Sell
Level 30.99
Williams %R
Neutral
Level -59.3168
50-day SMA
Sell
Level $17.63
MACD (12, 26)
Sell
Level -0.24
25-day Aroon Oscillator
Sell
Level -72
On Balance Volume
Neutral
Level 171M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.2742)
Sell
CA Score (Annual)
Level (-0.3944)
Buy
Beneish M-Score (Annual)
Level (-3.8235)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (0.532)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Healthcare Realty Trust, Inc. engages in providing real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R. Emery in 1992 and is headquartered in Nashville, TN.

Stock Forecast FAQ

In the current month, HR has received 2 Buy ratings 8 Hold ratings, and 0 Sell ratings. The HR average analyst price target in the past 3 months is $19.40.

  • Where Will Healthcare Realty Trust, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Healthcare Realty Trust, Inc. share price will rise to $19.40 per share over the next 12 months.

  • What Do Analysts Say About Healthcare Realty Trust, Inc.?

    Analysts are divided on their view about Healthcare Realty Trust, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Healthcare Realty Trust, Inc. is a Sell and believe this share price will drop from its current level to $18.00.

  • What Is Healthcare Realty Trust, Inc.'s Price Target?

    The price target for Healthcare Realty Trust, Inc. over the next 1-year time period is forecast to be $19.40 according to 10 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.

  • Is HR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Healthcare Realty Trust, Inc. is a Hold. 8 of 10 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of HR?

    You can purchase shares of Healthcare Realty Trust, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Healthcare Realty Trust, Inc. shares.

  • What Is The Healthcare Realty Trust, Inc. Share Price Today?

    Healthcare Realty Trust, Inc. was last trading at $17.41 per share. This represents the most recent stock quote for Healthcare Realty Trust, Inc.. Yesterday, Healthcare Realty Trust, Inc. closed at $17.40 per share.

  • How To Buy Healthcare Realty Trust, Inc. Stock Online?

    In order to purchase Healthcare Realty Trust, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
46
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 36x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 27x

Alerts

Buy
51
AAOI alert for Apr 4

Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.

Buy
59
SBAC alert for Apr 4

SBA Communications Corp. [SBAC] is up 18.96% over the past day.

Buy
55
VSAT alert for Apr 4

ViaSat, Inc. [VSAT] is up 18.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock